Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE)

BACKGROUND: The objective of the study was to evaluate the efficacy and safety of upadacitinib over 84 weeks in Japanese patients with active rheumatoid arthritis (RA) and an inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs. METHODS: All patients completing a 12-w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arthritis Res Ther
Hlavní autoři: Kameda, Hideto, Takeuchi, Tsutomu, Yamaoka, Kunihiro, Oribe, Motohiro, Kawano, Mitsuhiro, Yokoyama, Masayuki, Pangan, Aileen L., Konishi, Yuko, Meerwein, Sebastian, Tanaka, Yoshiya
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7789301/
https://ncbi.nlm.nih.gov/pubmed/33407801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02387-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky